Skip to content

AMNIOTIC MEMBRANE AND MINERAL TRIOXIDE AGGREGATE AS PULPOTOMY AGENTS IN PERMANENT MOLARS : A RANDOMIZED CONTROLLED TRIAL

COMPARATIVE EVALUATION OF AMNIOTIC MEMBRANE AND MINERAL TRIOXIDE AGGREGATE AS PULPOTOMY AGENTS IN PERMANENT MOLARS WITH SYMPTOMATIC IRREVERSIBLE PULPITIS: A RANDOMIZED CONTROLLED TRIAL - nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068056
Enrollment
54
Registered
2024-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: amniotic membrane as pulpotomy agent.: Complete pulpotomy, or complete pulp amputation, is a more intrusive procedure defined by the AAE as “The removal of the coronal portion of the v

Sponsors

Dr. Aakash Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with occlusal caries involving permanent molar teeth with complete root development and symptoms of irreversible pulpitis, i.e., Spontaneous, lingering pain exacerbated by hot and cold fluids, and/or radiating pain Patients which respond to cold and electric pulp testing and had no periapical involvement will be included in the study

Exclusion criteria

Exclusion criteria: 1.Patients with teeth having periapical widening will be excluded from the study 2.Patients having systemic diseases, on opioid or steroid therapy, or on any kind of antibiotic medication will be excluded from the study 3.Patients with teeth having marginal periodontitis or crestal bone loss, internal/external resorption, calcified canals, excessive bleeding after access cavity preparation not controlled after 5-10 minutes, or no bleeding at all will be excluded from the study

Design outcomes

Primary

MeasureTime frame
1.Radiographic evaluation of width of PDL space when MTA is used as a pulpotomy agent in permanent molars with symptomatic irreversible pulpitis 2. Radiographic evaluation of width of PDL space when amniotic membrane is used as a pulpotomy agent in permanent molars with symptomatic irreversible pulpitis 3.. Comparison of radiographic evaluation when amniotic membrane and MTA are used as pulpotomy agents in permanent molars with symptomatic irreversible pulpitisTimepoint: Radiographic assessment will be done after 1 month, 3 months,6 months and 1 year

Secondary

MeasureTime frame
4.Postoperative evaluation of pain when MTA is used as a pulpotomy agent in permanent molars with symptomatic irreversible pulpitis by using HEFT Parker scale 5. Postoperative evaluation of pain when amniotic membrane is used as a pulpotomy agent in permanent molars with symptomatic irreversible pulpitis by using HEFT Parker scale 6.Comparison of postoperative pain when amniotic membrane and MTA are used as pulpotomy agents in permanent molars with symptomatic irreversible pulpitisTimepoint: 12 HRS ,24 HRS ,48 HRS , 1 WEEK

Countries

India

Contacts

Public ContactDr Aakash Kumar

Manav Rachna Dental College

monikatandan.sds@mrei.ac.in9999063631

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026